SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 14.81 |
| Enterprise Value ($M) | 6.47 |
| Book Value ($M) | 10.00 |
| Book Value / Share | 5.31 |
| Price / Book | 1.48 |
| NCAV ($M) | -1.87 |
| NCAV / Share | -0.99 |
| Price / NCAV | -7.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.04 |
| Return on Equity (ROE) | -0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.74 |
| Current Ratio | 1.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28.70 |
| Assets | 40.57 |
| Liabilities | 30.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Robbins Marlin Ray | 5.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9 | 514 | 1.75 | |
| 4,403 | 7,856 | 56.05 | |
| 2,240 | 6,707 | 33.40 | |
| 13 | 132 | 9.85 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNPR – Monopar Therapeutics Inc. | MRKR – Marker Therapeutics, Inc. |
| MTEM – Molecular Templates, Inc. | MYNZ – Mainz Biomed N.V. |
| NATR – Nature's Sunshine Products, Inc. |
Financial data and stock pages provided by
Fintel.io